Tags: Monoclonal AntibodiesCancerAntibody ResearchBispecific AntibodiesDLBCL Trials
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts | ||
| 2 | Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA | ||
| 3 | Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | Advances in CAR T-Cell Therapy and Bispecifics for Relapsed/Refractory Multiple Myeloma - 22 days ago | |
| 4 | Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland | Study: Monoclonal Antibodies Benefit Those Previously Treated for HIV - about 1 year ago | |
| 5 | John Gever MedPage Today MedPage Today factotum. Pittsburgh, Pa. | Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupus - 2 months ago | |
| 6 | Meagan Parrish Pharma Voice Senior editor @industrydive.
Pharma world follower. Wisconsin, USA | Pharma’s ‘it’ therapy — a new drug class gaining steam - 2 months ago Red Jacket: Helen Sabzevari, an immunotherapy pioneer - about 1 year ago | |
| 7 | PharmaTimes PharmaTimes PharmaTimes Media Ltd. Digital health news. Surrey, United Kingdom | Oncimmune announces new contract with global pharma company - 3 months ago | |
| 8 | Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia | A potential MS ‘game changer’ could bring more safety to the table — even against viruses - 3 months ago Is a better CAR-T cell therapy option on the horizon? - 4 months ago | |
| 9 | <em>The Scientist</em> Staff The Scientist Exploring Life, Inspiring Innovation. | Boosting the Efficiency of Therapeutic Antibody Development - 4 months ago | |
| 10 | Crystal Phend MedPage Today Contributing editor at MedPage Today. Personal views. | What's on the Horizon for Myasthenia Gravis - about 1 year ago |